$852.35
-12.55-1.45%
At close: -
$853.00
0.650.08%
After Hours: 7:53 PM EDT
Eli Lilly reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eli Lilly using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly | $2.58 | $4.97 | — | — | $8.77B | $12.93B | — | — | 05/01/2025 | Get Alert |
LLY | Eli Lilly | $2.49 | $5.08 | $5.32 | 4.72% | $9.35B | $13.43B | $13.53B | 0.77% | 02/06/2025 | Get Alert |
LLY | Eli Lilly | $0.10 | $1.45 | $1.18 | -18.62% | $9.50B | $12.10B | $11.44B | -5.46% | 10/30/2024 | Get Alert |
LLY | Eli Lilly | $2.11 | $2.70 | $3.92 | 45.19% | $8.31B | $9.95B | $11.30B | 13.60% | 08/08/2024 | Get Alert |
LLY | Eli Lilly | $1.62 | $2.46 | $2.58 | 4.88% | $6.96B | $8.92B | $8.77B | -1.70% | 04/30/2024 | Get Alert |
LLY | Eli Lilly | $2.09 | $2.19 | $2.49 | 13.70% | $7.30B | $8.93B | $9.35B | 4.74% | 02/06/2024 | Get Alert |
LLY | Eli Lilly | $1.98 | -$0.15 | $0.10 | 166.67% | $6.94B | $8.95B | $9.50B | 6.13% | 11/02/2023 | Get Alert |
LLY | Eli Lilly | $1.25 | $1.99 | $2.11 | 6.03% | $6.49B | $7.58B | $8.31B | 9.66% | 08/08/2023 | Get Alert |
LLY | Eli Lilly | $2.62 | $1.73 | $1.62 | -6.36% | $7.81B | $6.86B | $6.96B | 1.46% | 04/27/2023 | Get Alert |
LLY | Eli Lilly | $2.49 | $1.78 | $2.09 | 17.42% | $8.00B | $7.33B | $7.30B | -0.38% | 02/02/2023 | Get Alert |
LLY | Eli Lilly | $1.77 | $1.92 | $1.98 | 3.12% | $6.77B | $6.91B | $6.94B | 0.46% | 11/01/2022 | Get Alert |
LLY | Eli Lilly | $1.87 | $1.69 | $1.25 | -26.04% | $6.74B | $6.70B | $6.49B | -3.16% | 08/04/2022 | Get Alert |
LLY | Eli Lilly | $1.87 | $2.13 | $2.62 | 23.00% | $6.81B | $6.68B | $7.81B | 16.92% | 04/28/2022 | Get Alert |
LLY | Eli Lilly | $2.75 | $2.19 | $2.49 | 13.70% | $7.44B | $6.90B | $8.00B | 15.94% | 02/03/2022 | Get Alert |
LLY | Eli Lilly | $1.54 | $1.68 | $1.94 | 15.48% | $5.74B | $5.70B | $6.77B | 18.82% | 10/26/2021 | Get Alert |
LLY | Eli Lilly | $1.89 | $1.92 | $1.87 | -2.60% | $5.50B | $6.65B | $6.74B | 1.35% | 08/03/2021 | Get Alert |
LLY | Eli Lilly | $1.75 | $2.14 | $1.87 | -12.62% | $5.86B | $7.02B | $6.81B | -3.05% | 04/27/2021 | Get Alert |
LLY | Eli Lilly | $1.73 | $2.35 | $2.75 | 17.02% | $6.11B | $7.29B | $7.44B | 2.06% | 01/29/2021 | Get Alert |
LLY | Eli Lilly | $1.48 | $1.71 | $1.54 | -9.94% | $5.48B | $5.91B | $5.74B | -2.86% | 10/27/2020 | Get Alert |
LLY | Eli Lilly | $1.50 | $1.56 | $1.89 | 21.15% | $5.64B | $5.76B | $5.50B | -4.53% | 07/30/2020 | Get Alert |
LLY | Eli Lilly | $1.33 | $1.48 | $1.75 | 18.24% | $5.09B | $5.51B | $5.86B | 6.35% | 04/23/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $5.32 | $5.08 | 4.72 % |
Q3 | 2024-10-30 | $1.18 | $1.45 | -18.6 % |
Q2 | 2024-08-08 | $3.92 | $2.70 | 45.2 % |
Q1 | 2024-04-30 | $2.58 | $2.46 | 4.88 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $13.53B | $13.43B | 0.77 % |
Q3 | 2024-10-30 | $11.44B | $12.10B | -5.46 % |
Q2 | 2024-08-08 | $11.30B | $9.95B | 13.6 % |
Q1 | 2024-04-30 | $8.77B | $8.92B | -1.70 % |
Eli Lilly (LLY) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 6, 2025 for Q4.
The Actual EPS was $5.32, which beat the estimate of $5.08.
The Actual Revenue was $13.5B, which beat the estimate of $13.4B.
Browse earnings estimates, EPS, and revenue on all stocks.